CN103214489A - 一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法 - Google Patents
一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法 Download PDFInfo
- Publication number
- CN103214489A CN103214489A CN2013100603199A CN201310060319A CN103214489A CN 103214489 A CN103214489 A CN 103214489A CN 2013100603199 A CN2013100603199 A CN 2013100603199A CN 201310060319 A CN201310060319 A CN 201310060319A CN 103214489 A CN103214489 A CN 103214489A
- Authority
- CN
- China
- Prior art keywords
- phenyl
- group
- amine
- base
- pyrimidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310060319.9A CN103214489B (zh) | 2013-02-25 | 2013-02-25 | 一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310060319.9A CN103214489B (zh) | 2013-02-25 | 2013-02-25 | 一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103214489A true CN103214489A (zh) | 2013-07-24 |
CN103214489B CN103214489B (zh) | 2016-10-26 |
Family
ID=48812697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310060319.9A Expired - Fee Related CN103214489B (zh) | 2013-02-25 | 2013-02-25 | 一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103214489B (und) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104788484A (zh) * | 2015-04-30 | 2015-07-22 | 杭州拜善晟生物科技有限公司 | 一种2-硝基苯基硼酸的合成方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1198743A (zh) * | 1995-10-02 | 1998-11-11 | 弗·哈夫曼-拉罗切有限公司 | 作为5HT2c-受体拮抗剂的嘧啶衍生物 |
WO2003050090A1 (en) * | 2001-11-27 | 2003-06-19 | Wyeth Holdings Corporation | 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
CN101631464A (zh) * | 2006-12-05 | 2010-01-20 | 拜耳先灵医药股份有限公司 | 用于治疗过度增殖疾病和血管发生相关性疾病的2,3-二氢咪唑并[1,2-c]喹唑啉取代衍生物 |
CN102906094A (zh) * | 2010-11-11 | 2013-01-30 | 拜耳知识产权有限责任公司 | 用于治疗过度增殖性病症和与血管发生相关的疾病的氨基醇取代的2,3-二氢咪唑并[1,2-c]喹唑啉衍生物 |
-
2013
- 2013-02-25 CN CN201310060319.9A patent/CN103214489B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1198743A (zh) * | 1995-10-02 | 1998-11-11 | 弗·哈夫曼-拉罗切有限公司 | 作为5HT2c-受体拮抗剂的嘧啶衍生物 |
WO2003050090A1 (en) * | 2001-11-27 | 2003-06-19 | Wyeth Holdings Corporation | 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
CN101631464A (zh) * | 2006-12-05 | 2010-01-20 | 拜耳先灵医药股份有限公司 | 用于治疗过度增殖疾病和血管发生相关性疾病的2,3-二氢咪唑并[1,2-c]喹唑啉取代衍生物 |
US20110083984A1 (en) * | 2006-12-05 | 2011-04-14 | Bayer Schering Pharma Aktiengesellschaft | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis |
CN102906094A (zh) * | 2010-11-11 | 2013-01-30 | 拜耳知识产权有限责任公司 | 用于治疗过度增殖性病症和与血管发生相关的疾病的氨基醇取代的2,3-二氢咪唑并[1,2-c]喹唑啉衍生物 |
Non-Patent Citations (4)
Title |
---|
MIZUHARA, TSUKASA 等: "Concise synthesis and anti-HIV activity of pyrimido[1,2-c][1,3]benzothiazin-6-imines and related tricyclic heterocycles", 《ORGANIC & BIOMOLECULAR CHEMISTRY》, vol. 10, no. 33, 22 June 2012 (2012-06-22) * |
PING YIN 等: "Synthesis of 2,4-Diaminoquinazolines and Tricyclic Quinazolines by Cascade Reductive Cyclization of Methyl N-Cyano-2-nitrobenzimidates", 《THE JOURNAL OF ORGANIC CHEMISTRY》, vol. 77, no. 6, 27 January 2012 (2012-01-27) * |
RENZHONG FU 等: "Rapid Access to Pyrimido[5,4-c]isoquinolines via a Sulfur Monoxide Extrusion Reaction", 《ORGANIC LETTERS》, vol. 9, no. 4, 20 January 2007 (2007-01-20) * |
周峰 等: "具新生血管抑制及血管阻断双重作用的肿瘤血管靶向药物研究进展", 《药学进展》, vol. 37, no. 1, 15 January 2013 (2013-01-15) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104788484A (zh) * | 2015-04-30 | 2015-07-22 | 杭州拜善晟生物科技有限公司 | 一种2-硝基苯基硼酸的合成方法 |
CN104788484B (zh) * | 2015-04-30 | 2017-01-11 | 杭州拜善晟生物科技有限公司 | 一种2-硝基苯基硼酸的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103214489B (zh) | 2016-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Design, synthesis and biological evaluation of novel thieno [3, 2-d] pyrimidine derivatives containing diaryl urea moiety as potent antitumor agents | |
EP3567043B1 (en) | 2-[[5-[(4-hydroxy-3-chloro-2-methyl)-phenyl]-thieno[2,3-d]pyrimidin-4-yl]oxy]-3-(2-methoxybenzene)propanoic acid derivatives as mcl-1 and bcl-2 inhibitors for treating cancer | |
Durgun et al. | Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII | |
EP2155734A2 (en) | Triazolyl aminopyrimidine compounds | |
Tang et al. | Discovery of novel 7-azaindole derivatives bearing dihydropyridazine moiety as c-Met kinase inhibitors | |
Umadevi et al. | Synthesis and in-vitro antibacterial activity of some new urea, thiourea and thiosemicarbazide derivatives | |
Li et al. | Design, Synthesis and Evaluation of Novel Rhodanine‐containing Sorafenib Analogs as Potential Antitumor Agents | |
KR20080093155A (ko) | 키나제 억제제로서의 헤테로비시클릭 카르복스아미드 | |
Ebenezer et al. | Antibacterial evaluation and molecular docking studies of pyrazole–thiosemicarbazones and their pyrazole–thiazolidinone conjugates | |
CN104803925A (zh) | 一类以 fgfr 为靶点的 2,4,5-三取代嘧啶类化合物及其制备方法和用途 | |
Abdelhameed et al. | Synthesis of arylidene hydrazinylpyrido [2, 3-d] pyrimidin-4-ones as potent anti-microbial agents | |
Jarrahpour et al. | Synthesis of novel mono-and bis-Schiff bases of morpholine derivatives and the investigation of their antimalarial and antiproliferative activities | |
Farooq et al. | One‐pot and two‐pot methods for chalcone derived pyrimidines synthesis and applications | |
Hu et al. | Design, synthesis and biological evaluation of novel thieno [3, 2-d] pyrimidine and quinazoline derivatives as potent antitumor agents | |
Ma et al. | Synthesis and Biological Evaluation of Benzothiazole Derivatives Bearing the ortho‐Hydroxy‐N‐acylhydrazone Moiety as Potent Antitumor Agents | |
Rashdana et al. | A novel approach of potent antioxidant and antimicrobial agents containing coumarin moiety accompanied with cytotoxicity studies on the newly synthesized derivatives | |
Quiroga et al. | Preparation of 6-chloropyrazolo [3, 4-b] pyridine-5-carbaldehydes by Vilsmeier–Haack reaction and its use in the synthesis of heterocyclic chalcones and dipyrazolopyridines | |
CN103450176A (zh) | 一类含2-(4-氨基苯基)苯并噻唑萘酰亚胺化合物及其应用 | |
Bhatt et al. | Synthesis of some bioactive sulfonamide and amide derivatives of piperazine incorporating imidazo [1, 2-B] pyridazine moiety | |
Patle et al. | Synthesis and evaluation of 2, 4, 6-trisubstituted pyrimidine derivatives as novel antileishmanial agents | |
Sridhar et al. | Synthesis and anticancer activity of some novel pyrimidine derivatives | |
Dave et al. | Syntheses and anti-microbial evaluation of new quinoline scaffold derived pyrimidine derivatives | |
Mettu et al. | Mechanistic investigations on substituted benzene sulphonamides as apoptosis inducing anticancer agents | |
Das et al. | An efficient stereo-controlled synthesis of bis-pyrimido-[4, 5-d]-pyrimidine derivatives via aza-Diels–Alder methodology and their preliminary bioactivity | |
CN103214489A (zh) | 一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20161026 Termination date: 20170225 |
|
CF01 | Termination of patent right due to non-payment of annual fee |